Pediatric Endocrinology

Symptoms & Biology: How IGHD Works

At a Glance

Non-acquired isolated growth hormone deficiency (IGHD) is a genetic condition present from birth that causes slow growth, belly fat, and "doll-like" facial features in children. It occurs due to mutations in the GH1 or GHRHR genes, preventing the pituitary gland from making enough growth hormone.

Understanding how Isolated Growth Hormone Deficiency (IGHD) affects your child begins with looking at the biological “machinery” of growth. In a child with non-acquired IGHD, the body’s natural system for producing or receiving growth signals is disrupted from birth ^[1]. This disruption leads to specific physical signs that help doctors distinguish IGHD from other causes of short stature ^[2]^[3].

Hallmark Signs and Symptoms

Children with IGHD often follow a very specific growth pattern. Because growth hormone affects more than just height, it can influence many aspects of a child’s physical development ^[4].

Growth Velocity: The most prominent sign is growth velocity, or the speed at which a child grows. Children with IGHD typically grow much slower than their peers, often falling further and further behind on growth charts over time ^[4]^[5].
“Doll-like” Features: Children with severe IGHD may have a characteristic facial appearance. This is often described as immature facies, where the face remains rounded and youthful (baby-like), the forehead is prominent, and the bridge of the nose is slightly flattened ^[2].
Truncal Obesity: Growth hormone helps the body break down fat. Without enough of it, children often develop truncal obesity, which is excess fat stored around the midsection or belly. The good news is that this typically improves significantly once growth hormone therapy begins ^[2]^[6].
Early Red Flags: In some infants, the first signs appear shortly after birth. These can include neonatal hypoglycemia (dangerously low blood sugar) or prolonged jaundice (yellowing of the skin) ^[7]^[8].

The Biology of IGHD: A Broken Signal

To understand why this happens, think of the body’s growth system as a relay race. In non-acquired IGHD, one of the key runners is either missing or unable to pass the baton.

1. The GHRHR Gene (The Receiver)

The GHRHR gene provides instructions for building a “receiver” on the surface of the pituitary gland. This receiver is meant to catch a signal from the brain that says, “It’s time to make growth hormone” ^[9]. When this gene has a mutation, the receiver is broken. The signal is sent, but the pituitary gland never “hears” it, so it doesn’t produce the hormone ^[10].

2. The GH1 Gene (The Product)

The GH1 gene contains the actual “blueprint” for the growth hormone molecule itself ^[1]. If this gene is mutated, the pituitary gland might “hear” the signal to grow, but it cannot build the hormone correctly ^[11]. In some cases (Type II IGHD), the body builds a “clogged” version of the hormone that actually gets stuck inside the gland, preventing any healthy hormone from getting out ^[1]^[12].

Differentiating IGHD from Other Conditions

It is important to understand that IGHD is a specific medical diagnosis, distinct from other reasons a child might be short.

Condition	Cause	Key Difference
Non-Acquired IGHD	Genetic mutations (GH1/GHRHR) present from birth ^[1].	Caused by a specific “broken blueprint” in the DNA ^[13].
Acquired GHD	External damage, such as a brain tumor, radiation, or head trauma ^[3].	The system worked fine at birth but was damaged later in life ^[14].
Idiopathic Short Stature (ISS)	Unknown; often a combination of many small genetic and environmental factors ^[15].	The child is short, but growth hormone levels often test as “normal” ^[16].

Unlike children with ISS, children with IGHD have a clear biological deficiency that can be replaced with therapy to significantly change their growth trajectory ^[6]^[17]. Regular monitoring is essential because, unlike ISS, true IGHD carries a small risk that other pituitary hormones could become deficient later in life ^[18].

Common questions in this guide

What are the first signs of isolated growth hormone deficiency in babies?

In some infants, the earliest signs appear shortly after birth. These early red flags can include dangerously low blood sugar, known as neonatal hypoglycemia, or prolonged jaundice.

Why does isolated growth hormone deficiency cause belly fat?

Growth hormone helps the body break down fat. When a child lacks sufficient growth hormone, they often develop truncal obesity, which is excess fat stored around the midsection. This typically improves once growth hormone therapy begins.

What do the facial features of a child with IGHD look like?

Children with severe IGHD may have immature or doll-like facial features. Their face often remains rounded and baby-like, with a prominent forehead and a slightly flattened nasal bridge.

How is IGHD different from idiopathic short stature?

While idiopathic short stature has no known clear cause and growth hormone levels often test normal, IGHD is caused by specific genetic mutations. Children with non-acquired IGHD have a clear biological deficiency that requires treatment.

Which genes cause non-acquired isolated growth hormone deficiency?

Non-acquired IGHD is often caused by mutations in the GH1 or GHRHR genes. A mutated GHRHR gene prevents the pituitary gland from receiving the signal to make growth hormone, while a GH1 mutation affects the body's ability to build the hormone correctly.

Curated prompts to bring to your next appointment.

1.Based on my child's growth pattern, would you characterize their height as significantly below the 'mid-parental height' target?
2.Does my child have any 'doll-like' facial features or truncal obesity that are classic markers of IGHD?
3.Since this is non-acquired IGHD, which specific gene (like GH1 or GHRHR) do you suspect is involved, and should we do genetic testing to confirm?
4.How does my child's 'bone age' compare to their actual age, and what does that tell us about their growth potential?
5.Could my child's history of low blood sugar or jaundice at birth have been an early sign of this condition?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (18)

1
Isolated growth hormone deficiency due to the R183H mutation in GH1: Clinical analysis of a four-generation family.
Cabrera-Salcedo C, Shah AS, Andrew M, et al.
Clinical endocrinology 2017; (87(6)):874-876 doi:10.1111/cen.13400.
PMID: 28626954
2
Growth Hormone Deficiency in Children: From Suspecting to Diagnosing.
Vyas V, Kumar A, Jain V
Indian pediatrics 2017; (54(11)):955-960 doi:10.1007/s13312-017-1190-3.
PMID: 29217803
3
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.
Child CJ, Blum WF, Deal C, et al.
European journal of endocrinology 2016; (174(5)):669-79 doi:10.1530/EJE-15-1203.
PMID: 26888628
4
[Somatropin and final height in Mexican paediatric population with growth hormone deficiency].
Rivera-Hernández A, Sánchez-García F, Zurita-Cruz J, Balcázar-Hernández L
Andes pediatrica : revista Chilena de pediatria 2022; (93(4)):496-503 doi:10.32641/andespediatr.v93i4.3763.
PMID: 37906847
5
Preliminary study of longitudinal changes in the pituitary and brain of children on growth hormone therapy.
Low LS, Wong JHD, Tan LK, et al.
Journal of neuroradiology = Journal de neuroradiologie 2023; (50(2)):271-277 doi:10.1016/j.neurad.2021.11.004.
PMID: 34800564
6
Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency.
Smuel K, Kauli R, Lilos P, Laron Z
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2015; (25(4)):182-8.
PMID: 26077773
7
Congenital Hypopituitarism.
Parks JS
Clinics in perinatology 2018; (45(1)):75-91 doi:10.1016/j.clp.2017.11.001.
PMID: 29406008
8
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency.
Sridhar S, Raja BR, Priyanka R, et al.
Pituitary 2023; (26(5)):622-628 doi:10.1007/s11102-023-01351-2.
PMID: 37695468
9
Genetic Anomalies of Growth Hormone Deficiency in Pediatrics.
Firouzi M, Sherkatolabbasieh H, Shafizadeh S
Endocrine, metabolic & immune disorders drug targets 2021; (21(2)):288-297 doi:10.2174/1871530320666200704144912.
PMID: 32621723
10
Pathogenic and likely pathogenic genetic alterations and polymorphisms in growth hormone gene (GH1) and growth hormone releasing hormone receptor gene (GHRHR) in a cohort of isolated growth hormone deficient (IGHD) children in Sri Lanka.
Sundralingam T, Tennekoon KH, de Silva S, et al.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2017; (36()):22-29 doi:10.1016/j.ghir.2017.08.006.
PMID: 28910730
11
Autosomal Dominant Growth Hormone Deficiency (Type II).
Alatzoglou KS, Kular D, Dattani MT
Pediatric endocrinology reviews : PER 2015; (12(4)):347-55.
PMID: 26182479
12
Isolated Growth Hormone Deficiency Type 2 due to a novel GH1 Mutation: A Case Report
Kautsar A, Wit JM, Pulungan A
Journal of clinical research in pediatric endocrinology 2019; (11(4)):426-431 doi:10.4274/jcrpe.galenos.2019.2018.0305.
PMID: 30678423
13
Contribution of functionally assessed GHRHR mutations to idiopathic isolated growth hormone deficiency in patients without GH1 mutations.
Cohen E, Belkacem S, Fedala S, et al.
Human mutation 2019; (40(11)):2033-2043 doi:10.1002/humu.23847.
PMID: 31231873
14
Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study.
Deal C, Kirsch S, Chanoine JP, et al.
CMAJ open 2018; (6(3)):E372-E383 doi:10.9778/cmajo.20180020.
PMID: 30201821
15
Long-Term Outcomes, Genetics, and Pituitary Morphology in Patients with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies: A Single-Centre Experience of Four Decades of Growth Hormone Replacement.
Rohayem J, Drechsel H, Tittel B, et al.
Hormone research in paediatrics 2016; (86(2)):106-116 doi:10.1159/000448098.
PMID: 27487097
16
Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
Child CJ, Quigley CA, Cutler GB, et al.
Hormone research in paediatrics 2019; (91(4)):241-251 doi:10.1159/000500087.
PMID: 31185471
17
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height.
Ariza-Jimenez AB, Leiva Gea I, Martinez-Aedo Ollero MJ, Lopez-Siguero JP
Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10214988.
PMID: 34768508
18
Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency.
Cerbone M, Dattani MT
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2017; (37()):19-25 doi:10.1016/j.ghir.2017.10.005.
PMID: 29107171

This page explains the symptoms and biology of IGHD for educational purposes only. Always consult a pediatric endocrinologist for an accurate diagnosis and personalized treatment plan for your child's growth.

Get notified when new evidence is published on Non-acquired isolated growth hormone deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents